%D8%A3%D9%85%D9%81%D9%88%D8%AA%D9%8A%D8%B1%D9%8A%D8%B3%D9%8A%D9%86_%D8%A8Category:AmphotericinsAmffotericin_BAmphotericin_BAmphotericin_BAnfotericina_BB_anfoterizina%D8%A2%D9%85%D9%81%D9%88%D8%AA%D8%B1%DB%8C%D8%B3%DB%8C%D9%86_%D8%A8%DB%8CAmfoterisiini_BAmphot%C3%A9ricine_BAmfotericin_BAmfoterisin_BAmfotericina_B%E3%82%A2%E3%83%A0%E3%83%9B%E3%83%86%E3%83%AA%E3%82%B7%E3%83%B3B%EC%95%94%ED%8F%AC%ED%85%8C%EB%A6%AC%EC%8B%A0_BAmfotericine_B%E0%AC%86%E0%AC%AE%E0%AD%8D%E0%AC%AB%E0%AD%8B%E0%AC%9F%E0%AD%87%E0%AC%B0%E0%AC%BF%E0%AC%B8%E0%AC%BF%E0%AC%A8_%E0%AC%AC%E0%AC%BFAmfoterycyna_BAnfotericina_BAmfotericin%C4%83_B%D0%90%D0%BC%D1%84%D0%BE%D1%82%D0%B5%D1%80%D0%B8%D1%86%D0%B8%D0%BD_BAmfotericin_BAmfotericin_BAmfotericin_B%E0%B0%8F%E0%B0%82%E0%B0%AB%E0%B1%8B%E0%B0%9F%E0%B1%86%E0%B0%B0%E0%B0%BF%E0%B0%B8%E0%B0%BF%E0%B0%A8%E0%B1%8D_%E0%B0%AC%E0%B0%BF%E0%B9%81%E0%B8%AD%E0%B8%A1%E0%B9%82%E0%B8%9F%E0%B9%80%E0%B8%97%E0%B8%AD%E0%B8%A3%E0%B8%B4%E0%B8%8B%E0%B8%B4%E0%B8%99%E0%B8%9A%E0%B8%B5%D0%90%D0%BC%D1%84%D0%BE%D1%82%D0%B5%D1%80%D0%B8%D1%86%D0%B8%D0%BD_%D0%92Amphotericin_BQ412223%E4%B8%A4%E6%80%A7%E9%9C%89%E7%B4%A0B
about
sameAs
P3781
Prospective Evaluation of the Effects of Topical Therapy With Sulfamylon® For 5% Topical Solution on Autograft Healing in Subjects With Thermal Injuries Requiring Meshed Autografts: A Comparison to a Historical Control GroupA Phase II Study To Assess Safety and Efficacy Of Short-Course Regimens Of Amphotericin B Emulsion In Kala-AzarAntimicrobial PK in Infants With Suspected or Confirmed InfectionIntermittent Liposomal Amphotericin B Primary ProphylaxisAmphotericin B Suspension in Refractory Chronic SinusitisAmbisome and Management of Culture-negative Neutropenic Fever Unresponsive to AntibioticsThe Deferasirox-AmBisome Therapy for Mucormycosis (DEFEAT Mucor) StudyLiposomal Amphotericin B (Ambisome) Versus Oral Voriconazole for the Prevention of Invasive Fungal InfectionsShort Course of Miltefosine and Liposomal Amphotericin B for Kala-azarCombination Chemotherapy for the Treatment of Indian Kala-AzarPROPHYSOME: Pilot Study on Safety of a Weekly Administration of 10mg/kg of AmBisome® in Antifungal Prophylaxis Treatment of Allogeneic Stem-cell Transplantation and Acute LeukaemiaClinical Trial to Assess the Safety and Efficacy of Sodium Stibogluconate (SSG) and AmBisome® Combination, Miltefosine and AmBisome® and Miltefosine Alone for the Treatment Visceral Leishmaniasis in Eastern AfricaCaspofungin Based Combined Anti-fungal Therapy for Proven or Probable Invasive Fungal InfectionChronic Pulmonary Aspergillosis and Ambisome Aerosol With ItraconazoleMicafungin Versus AmBisome in Invasive Candidiasis and CandidemiaComparison of Voriconazole and Amphotericin B in Treating Patients With AspergillosisA Post Marketing Surveillance Study of Lipo-AB® (Amphotericin B) in Neutropenic Patients With Persistent FeverSingle Dose Liposomal Amphotericin B for Visceral LeishmaniasisAnidulafungin vs Amphotericin B Safety in High Risk Hepatic Transplant RecipientsEfficacy and Safety Study of Drugs for Treatment of Visceral Leishmaniasis in BrazilA Study to Compare the Efficacy and Safety of a Combination of Ketoconazole and Clindamycin Compared to Tetracycline/Amphotericin B Combination Cream for the Treatment of Bacterial Vaginosis and Vaginal Candidiasis (P08077)Steady State Global Bioequivalence Study of Amphotericin B Liposome for Injection 50 mg/ Vial in Fed ConditionShort Course Regimens for Treatment of PKDL (Sudan)VL-2397 Compared to Standard First-Line Treatment for Invasive Aspergillosis (IA) in AdultsSafety and Effectiveness of Short-course AmBisome in the Treatment of PKDL in BangladeshTopical Amphotericin B in 30% Dimethylsulphoxide in Treating of Non-dermatophytes OnychomycosisEvaluation of a Therapeutic Strategy Including Nebulised Liposomal Amphotericin B (Ambisome®) in Maintenance Treatment of Allergic Bronchopulmonary Aspergillosis (Cystic Fibrosis Excluded).Prevention of Invasive Fungal Infections (IFIs) in Subjects Receiving Chemotherapy for Acute Lymphoblastic LeukemiaSafety and Efficacy Study of Inhaled AmBisome for Prevention of Aspergillus Colonization in Lung Transplant RecipientsPhase III, Study of Three Short Course Combo (Ambisome®, Miltefosine, Paromomycin) Compared With AmBisome for the Treatment of VL in BangladeshAntimycotic Prophylaxis in Pediatric Patients Following Allogeneic Stem Cell TransplantationAmphotericin B to Treat Visceral Leishmaniasis in Brazilian ChildrenAn Bioequivalence Study to Compare Two 2 mg/ml Liposomal Amphotericin B Injections in Healthy SubjectsSafety, Efficacy, and Pharmacokinetics of Amphotericin B Lipid ComplexNebulized Amphotericin B Lipid Complex in Invasive Pulmonary Aspergillosis in Paediatric Patients With Acute LeukaemiaAmbisome® Preemptive Treatment of Multiple Candida Colonization in Sepsis PatientsSafety and Efficacy Study to Evaluate Different Combination Treatment Regimens for Visceral LeishmaniasisCRITIC - Treatment of Candidemia and Invasive CandidiasisLiposomal Amphotericin in Disseminated LeishmaniasisEfficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients.
P4844
Amphotericin B versus fluconazole for controlling fungal infections in neutropenic cancer patientsSynthesis, specificity, and antifungal activity of inhibitors of the Candida albicans delta 24-sterol methyltransferaseManagement of systemic fungal infections: alternatives to itraconazole.The interactions of amphotericin B with various sterols in relation to its possible use in anticancer therapy.A randomized open label trial of tamoxifen combined with amphotericin B and fluconazole for cryptococcal meningitisEUCAST Determination of Olorofim (F901318) Susceptibility of Mold Species, Method Validation, and MICsEffect of amphotericin B and voriconazole on the outgrowth of conidia of Aspergillus fumigatus followed by time-lapse microscopyThe Development of Oral Amphotericin B to Treat Systemic Fungal and Parasitic Infections: Has the Myth Been Finally Realized?Vision loss in an AIDS patient with cryptococcal meningitisRecent Findings in Onychomycosis and Their Application for Appropriate TreatmentIn Vitro and In Vivo Evaluation of Voriconazole-Containing Antifungal Combinations against Mucorales Using a Model of MucormycosisDectin-1-Targeted Antifungal Liposomes Exhibit Enhanced EfficacyNoncovalent Complexation of Amphotericin B with Poly(β-Amino Ester) Derivates for Treatment of InfectionMucor menace in an immunocompetent young male after dental manipulationMucormycotic osteomyelitis of maxilla following maxillofacial trauma: The disease of the diseasedAmphotericin B is still the drug of choice for invasive aspergillosisSynthesis, structure and biological activity of pseudopeptidic macrolides based on an amino alcohol
P921
Q1435822-F36DB694-72B9-4ED1-8AEA-EC72460B350EQ1470140-90D978BD-0696-4EF7-8D82-6A95A8F515D8Q2046113-53DE09DE-5082-4DB8-AD00-DEE86A985F84Q221668-D34B4BC9-8FF2-4E5C-83E0-A78ADF2007E7Q223102-210B8CBD-03EE-4F69-8D1E-F5F22B502F67Q246084-7633CBA9-402C-4AA0-9D0C-475B40C972B7Q247096-9A31AF8C-8794-488A-B463-D1C0F37C1A60Q259626-C6B2DD6A-92AC-45DF-8C38-EB01BED2DE33Q26985509-2B9A68D2-1752-4F4D-9ECD-0923C42FBCF3Q273510-B88AC037-7EAA-49E8-A96F-4B6CA63FA4DCQ464067-9072C298-6BF5-4C1D-999D-114EC233AEF7Q5380626-D073E078-B046-4B69-9600-6569DB655649Q5509169-6724F78B-EB41-49A5-950D-38F9CF75216EQ627368-30042731-F001-40D0-A76E-43D72F26E631Q627625-842A73C5-0F9B-4AC9-A595-9035DBBE74EEQ767327-B31294E9-4599-4396-A009-2ADBD97E6C9DQ868137-77C929B7-C0CF-4D21-9BC0-10702EA1008C
P2176
Q61915538-EAB66780-D585-4D27-B8C5-634A215442CDQ61917395-1403CD9B-5C20-48ED-89A3-4C7EAFEFF42BQ61917969-2E57B1E9-AE16-49E9-B878-9AF0A9A248A3Q61920933-01771C3C-74A3-4D05-992B-A8A2C74D0D84Q61921500-1F00A4F1-D9B8-46FF-9092-50A460F00792Q61921897-C144B03A-A3A1-4CE8-A116-B7B91E4C3ABDQ61922040-D802C032-26EB-47E2-9C7F-A48D56863848Q61922131-8259A5BE-D6C7-4193-984D-7DE511B7BF5FQ61933060-7C363866-F0A3-47E7-84D8-F7441FD7117EQ61933259-51DD478B-BA79-49BB-8D0C-5070EFD095FBQ61934845-013AADB5-FEA4-423B-9C1F-BF6957A2C50CQ61939142-01A04F16-44D1-4439-B77B-E871025D5BB9Q61957562-09EFFB84-72BD-4C98-9AE2-9FD5754626AAQ62024923-E42035B7-E05F-4AD9-81C6-B537515C7717Q62105717-4701E1F1-744D-4C85-B265-49388E934451Q62110909-99F95AC2-16E7-4BA7-BDBD-B82E1CC3182AQ62820109-190DA176-7343-4E56-B99B-0B201AC2DA2EQ63318322-8F5B6D44-D0C2-42B4-BD8A-6873611D0C5EQ63337054-C07077F6-36E6-4409-B71A-07C0F07BFD61Q63339272-7B289983-6520-4321-9890-564F02431D57Q63339457-1D9D1B53-6CB4-4070-9214-ACD68B06492BQ63394062-2C4FBD62-6C4F-4668-88D6-679CC45B48E4Q63402242-B7CC86AE-384F-4C50-BFBC-286D4B0D70A1Q63534140-71AAB8CF-BA31-4B05-8C01-79805C819265Q63571643-463E69CE-30C5-4F17-BABA-F329856763E3Q63582540-ADF3154A-DD33-41F4-A470-2BA0E1C49896Q63813443-DD7487AB-53DE-4B41-8E0C-F1A9576C4207Q63817614-AFE1F67C-2E4D-4AF5-90C1-1A0972E8DC8BQ63818362-482674D4-9268-42DB-9C1D-7B891B4EC106Q63829674-A2115D3A-CC86-4CE1-9B28-239C63529165Q63833904-60480383-20B1-417F-9631-E1A53EC2C4A0Q63836786-30B2DB30-A59E-4FE4-B677-15DB314BD790Q63837956-ABF82D8B-62B1-4FD2-92C6-6B3BD1714228Q63841344-4BCA866A-AD33-40C8-8F25-F07FD16E215FQ63842871-613B2DF1-52AE-4C73-9C4C-AB6C286E2A73Q64043400-A14BDF6F-975D-4B54-BAB4-D6FF69FE65D2Q64043600-86749532-C3D9-4782-86C7-0DD1AACD07E5Q64047787-3E043B6F-AE33-4690-B79F-5EDBD5D32C25Q64349809-C4FE7D12-9424-4283-9A94-3880A2F6033EQ64351031-ED9531A5-89B6-427D-BFCB-794C12A0A836
P4844
Q24193785-bab6fc9c-4a72-6805-e8c7-cfb26e3de65dQ28324448-9DC6E188-399B-4E8B-87A8-B632C7ADCFD6Q36239984-C596CE46-7074-478B-9686-BEF73DCACB85Q43655465-593759D8-68E7-49EE-B964-813C4456BE97Q62737339-C3306BBE-B130-466F-A295-824F095C7BFAQ63727962-799295B8-B957-4B26-B0F7-A65E65ACC87CQ64078668-21A512E0-C94C-49FE-A8DA-C7612D6DE742Q64102682-D64797D5-B7E3-44EA-BB7C-C4284D373313Q64109779-9F77893E-970B-4853-8F09-4065B7E7CE0EQ64112076-53244DEA-5905-43C3-9E5C-28934B608DF7Q64228918-98BF1E50-4C60-4699-B8BD-8AA8114510FCQ64241497-036A5463-8EEC-44AC-A0BA-6F4B9DC37290Q64265678-D91735A5-4652-41AE-BC32-1A5FD0F7DBDFQ64281494-3E2C83CB-A3DD-409B-AEA8-32DE014C9B59Q64281804-DF34714E-EBFB-4C49-A75D-8E0FF2E1F3C0Q79774558-6C9FBD35-2C90-4EEB-8477-82B8944EB3EAQ80345649-85136D77-68C9-4AEF-912A-3C364A8717AF
P921
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Amfotericin B
@hu
Amfotericin B
@sh
Amfotericin B
@sl
Amfotericina B
@it
Amfotericină B
@ro
Amfoterisiini B
@fi
Amfoterisin B
@id
Amphotericin B
@de
Amphotericin B
@nl
Amphotericin B
@vi
type
label
Amfotericin B
@hu
Amfotericin B
@sh
Amfotericin B
@sl
Amfotericina B
@it
Amfotericină B
@ro
Amfoterisiini B
@fi
Amfoterisin B
@id
Amphotericin B
@de
Amphotericin B
@nl
Amphotericin B
@vi
altLabel
1397-89-3
@fr
AMPH-b
@cy
AMPH-b
@en
APT370
@en
Abelcet
@cy
Abelcet
@en
Abelcet
@fr
AmBisome
@pl
Ambisome
@cy
Ambisome
@en
prefLabel
Amfotericin B
@hu
Amfotericin B
@sh
Amfotericin B
@sl
Amfotericina B
@it
Amfotericină B
@ro
Amfoterisiini B
@fi
Amfoterisin B
@id
Amphotericin B
@de
Amphotericin B
@nl
Amphotericin B
@vi